| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neuroligin family protein binding | 1.25e-06 | 5 | 101 | 3 | GO:0097109 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 1.40e-05 | 64 | 99 | 5 | GO:1903351 | |
| GeneOntologyBiologicalProcess | response to dopamine | 1.63e-05 | 66 | 99 | 5 | GO:1903350 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 1.89e-05 | 68 | 99 | 5 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 1.89e-05 | 68 | 99 | 5 | GO:0071870 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | GSK3A IFNA7 GSK3B IFNA14 NRXN1 CSNK2A1 POGLUT2 MAPK13 CSNK2A3 | 2.31e-05 | 319 | 99 | 9 | GO:0018209 |
| GeneOntologyBiologicalProcess | intracellular transport | TRAPPC11 PSEN1 IPO7 TM9SF4 GSK3B LRPPRC SETD2 YIF1B MDN1 AP1B1 AP2B1 WDR35 RABGEF1 IFT122 NUP93 AP4B1 OAZ3 SFN SNX5 SMG6 | 2.41e-05 | 1496 | 99 | 20 | GO:0046907 |
| GeneOntologyBiologicalProcess | response to catecholamine | 2.67e-05 | 73 | 99 | 5 | GO:0071869 | |
| GeneOntologyBiologicalProcess | response to monoamine | 2.85e-05 | 74 | 99 | 5 | GO:0071867 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 5.74e-05 | 16 | 99 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | ERBB4 PSEN1 IPO7 TM9SF4 SIN3A GSK3A ADCYAP1 GSK3B USP8 SETD2 NRXN1 AP2B1 CSNK2A1 PRKG2 OAZ3 SFN | 5.77e-05 | 1087 | 99 | 16 | GO:0032880 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 5.84e-05 | 278 | 99 | 8 | GO:0031503 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | ERBB4 PSEN1 IPO7 TM9SF4 SIN3A GSK3A ADCYAP1 GSK3B USP8 SETD2 P2RX4 NRXN1 AP2B1 CSNK2A1 PRKG2 OAZ3 SFN | 6.00e-05 | 1212 | 99 | 17 | GO:0060341 |
| GeneOntologyBiologicalProcess | heart development | ERBB4 PSEN1 PLXND1 NEB GSK3A GSK3B GREB1L SETD2 AP1B1 AP2B1 IFT122 PCNA SOS1 | 6.67e-05 | 757 | 99 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of type B pancreatic cell development | 6.82e-05 | 3 | 99 | 2 | GO:2000077 | |
| GeneOntologyBiologicalProcess | negative regulation of glycogen (starch) synthase activity | 6.82e-05 | 3 | 99 | 2 | GO:2000466 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | SLC26A3 PSEN1 HTR7 SIN3A GSK3A IFNA7 GSK3B IFNA14 SETD2 SLC24A4 P2RX4 TAAR1 MMP3 MAPK13 PCNA SNX5 SOS1 | 1.09e-04 | 1272 | 99 | 17 | GO:1901698 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.16e-04 | 307 | 99 | 8 | GO:0018105 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.19e-04 | 308 | 99 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | ERBB4 PSEN1 IPO7 TM9SF4 GSK3A GSK3B NRXN1 AP2B1 PRKG2 OAZ3 SFN | 1.25e-04 | 591 | 99 | 11 | GO:1903829 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | ERBB4 PSEN1 IPO7 CCNJ GSK3A ADCYAP1 GSK3B NRXN1 PTPRQ SPDYA PCNA SFN SMG6 | 1.31e-04 | 810 | 99 | 13 | GO:0051338 |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 1.36e-04 | 4 | 99 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | ERBB4 TM9SF4 GSK3B NRXN3 YIF1B NRXN1 NRXN2 AP2B1 CSNK2A1 RABGEF1 IFT122 PRKG2 | 1.41e-04 | 705 | 99 | 12 | GO:0072657 |
| GeneOntologyBiologicalProcess | positive regulation of cAMP-mediated signaling | 1.77e-04 | 23 | 99 | 3 | GO:0043950 | |
| GeneOntologyBiologicalProcess | response to cytokine | SIN3A ACKR4 GSK3A IFNA7 GSK3B IFNA14 SETD2 IL1F10 ACKR3 IL21R NR5A2 WDR35 RABGEF1 MAPK13 SOS1 | 1.97e-04 | 1083 | 99 | 15 | GO:0034097 |
| GeneOntologyBiologicalProcess | vocalization behavior | 2.02e-04 | 24 | 99 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | SIN3A ACKR4 GSK3A IFNA7 GSK3B IFNA14 IL1F10 ACKR3 IL21R NR5A2 WDR35 RABGEF1 MAPK13 SOS1 | 2.09e-04 | 967 | 99 | 14 | GO:0071345 |
| GeneOntologyBiologicalProcess | positive regulation of amyloid fibril formation | 2.26e-04 | 5 | 99 | 2 | GO:1905908 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 2.26e-04 | 5 | 99 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | dorsal/ventral neural tube patterning | 2.28e-04 | 25 | 99 | 3 | GO:0021904 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | EGLN3 ERBB4 PSEN1 GSK3A IFNA7 GSK3B IFNA14 SETD2 NRXN1 CSNK2A1 FOLH1B POGLUT2 MAPK13 CSNK2A3 | 2.30e-04 | 976 | 99 | 14 | GO:0018193 |
| GeneOntologyBiologicalProcess | protein localization to synapse | 2.33e-04 | 115 | 99 | 5 | GO:0035418 | |
| GeneOntologyBiologicalProcess | response to peptide | SIN3A ACKR4 GSK3A IFNA7 GSK3B IFNA14 SETD2 IL1F10 ACKR3 IL21R NR5A2 WDR35 RABGEF1 MAPK13 SOS1 | 2.33e-04 | 1100 | 99 | 15 | GO:1901652 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular protein transport | 2.42e-04 | 116 | 99 | 5 | GO:0090316 | |
| GeneOntologyBiologicalProcess | membrane assembly | 2.54e-04 | 64 | 99 | 4 | GO:0071709 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | SLC26A3 PSEN1 HTR7 SIN3A GSK3A GSK3B P2RX4 TAAR1 MMP3 MAPK13 SNX5 SOS1 | 2.56e-04 | 752 | 99 | 12 | GO:1901699 |
| GeneOntologyBiologicalProcess | nuclear export | 2.70e-04 | 185 | 99 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.97e-04 | 266 | 99 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 3.04e-04 | 67 | 99 | 4 | GO:0099171 | |
| GeneOntologyBiologicalProcess | organelle assembly | PSEN1 MYOM3 NEB GSK3B DNAH1 NRXN3 YIF1B MDN1 NRXN1 AP1B1 NRXN2 ASPM WDR35 IFT122 YWHAQ | 3.35e-04 | 1138 | 99 | 15 | GO:0070925 |
| GeneOntologyBiologicalProcess | apoptotic mitochondrial changes | 3.96e-04 | 129 | 99 | 5 | GO:0008637 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 4.22e-04 | 73 | 99 | 4 | GO:0044091 | |
| GeneOntologyBiologicalProcess | presynapse organization | 4.22e-04 | 73 | 99 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | localization within membrane | ERBB4 TM9SF4 GSK3B NRXN3 YIF1B NRXN1 NRXN2 AP2B1 CSNK2A1 RABGEF1 IFT122 PRKG2 | 4.37e-04 | 798 | 99 | 12 | GO:0051668 |
| GeneOntologyBiologicalProcess | synapse organization | ERBB4 PSEN1 CHD4 PLXND1 GSK3B IL1RAPL1 NRXN3 NRXN1 NRXN2 TLN2 SPARCL1 | 4.45e-04 | 685 | 99 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | response to interleukin-3 | 4.71e-04 | 7 | 99 | 2 | GO:0036015 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-3 | 4.71e-04 | 7 | 99 | 2 | GO:0036016 | |
| GeneOntologyBiologicalProcess | vocal learning | 4.71e-04 | 7 | 99 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | imitative learning | 4.71e-04 | 7 | 99 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 4.71e-04 | 7 | 99 | 2 | GO:0060831 | |
| GeneOntologyBiologicalProcess | nuclear transport | 4.74e-04 | 378 | 99 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 4.74e-04 | 378 | 99 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 5.17e-04 | 77 | 99 | 4 | GO:0061512 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | APH1B ERBB4 PSEN1 HTR7 GSK3A ADCYAP1 GSK3B IL1RAPL1 USP8 NRXN3 P2RX4 NRXN1 NRXN2 | 5.46e-04 | 939 | 99 | 13 | GO:0099537 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 5.76e-04 | 34 | 99 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | epithelium development | ERBB4 PSEN1 IPO7 PLXND1 GSK3A GSK3B TULP3 GREB1L TGM3 SETD2 FRMD6 PTPRQ NR5A2 IFT122 DNASE1L2 SFN SOS1 | 5.88e-04 | 1469 | 99 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of glycogen (starch) synthase activity | 6.27e-04 | 8 | 99 | 2 | GO:2000465 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 7.40e-04 | 148 | 99 | 5 | GO:1902414 | |
| GeneOntologyBiologicalProcess | synaptic signaling | APH1B ERBB4 PSEN1 HTR7 GSK3A ADCYAP1 GSK3B IL1RAPL1 USP8 NRXN3 P2RX4 NRXN1 NRXN2 | 7.83e-04 | 976 | 99 | 13 | GO:0099536 |
| GeneOntologyBiologicalProcess | autosome genomic imprinting | 8.03e-04 | 9 | 99 | 2 | GO:0141068 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 8.03e-04 | 9 | 99 | 2 | GO:1901030 | |
| GeneOntologyBiologicalProcess | observational learning | 8.03e-04 | 9 | 99 | 2 | GO:0098597 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 8.14e-04 | 228 | 99 | 6 | GO:0045732 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | PSEN1 IPO7 TM9SF4 GSK3B AP1B1 AP2B1 NUP93 AP4B1 OAZ3 SFN SNX5 | 8.42e-04 | 740 | 99 | 11 | GO:0006886 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 9.10e-04 | 233 | 99 | 6 | GO:0050806 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PSEN1 RAPH1 SIN3A PLXND1 ARHGEF25 GSK3B IL1RAPL1 NRXN3 NRXN1 PTPRQ SOS1 | 9.19e-04 | 748 | 99 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cAMP-mediated signaling | 9.32e-04 | 40 | 99 | 3 | GO:0043949 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell development | 1.00e-03 | 10 | 99 | 2 | GO:2000074 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.00e-03 | 10 | 99 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | Notch receptor processing | 1.00e-03 | 10 | 99 | 2 | GO:0007220 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.01e-03 | 92 | 99 | 4 | GO:0034340 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | ERBB4 PSEN1 IPO7 CCNJ GSK3A ADCYAP1 IFNA7 GSK3B IFNA14 NRXN1 PTPRQ SPDYA RABGEF1 SFN | 1.01e-03 | 1133 | 99 | 14 | GO:0001932 |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 1.05e-03 | 160 | 99 | 5 | GO:0051384 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.07e-03 | 42 | 99 | 3 | GO:0099560 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 1.11e-03 | 162 | 99 | 5 | GO:0032388 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | ERBB4 PSEN1 IPO7 CCNJ GSK3A ADCYAP1 IFNA7 GSK3B IFNA14 NRXN1 PTPRQ SPDYA RABGEF1 CAMTA1 SFN SMG6 | 1.16e-03 | 1421 | 99 | 16 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | ERBB4 PSEN1 IPO7 CCNJ GSK3A ADCYAP1 IFNA7 GSK3B IFNA14 NRXN1 PTPRQ SPDYA RABGEF1 CAMTA1 SFN SMG6 | 1.18e-03 | 1423 | 99 | 16 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | 1.18e-03 | 96 | 99 | 4 | GO:0000079 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 1.22e-03 | 11 | 99 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.22e-03 | 11 | 99 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | learned vocalization behavior or vocal learning | 1.22e-03 | 11 | 99 | 2 | GO:0098598 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 1.23e-03 | 44 | 99 | 3 | GO:0007212 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 1.23e-03 | 44 | 99 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.24e-03 | 166 | 99 | 5 | GO:0098773 | |
| GeneOntologyBiologicalProcess | neural tube patterning | 1.31e-03 | 45 | 99 | 3 | GO:0021532 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiac muscle hypertrophy | 1.31e-03 | 45 | 99 | 3 | GO:0010614 | |
| GeneOntologyBiologicalProcess | circulatory system development | ERBB4 PSEN1 PLXND1 NEB GSK3A GSK3B GREB1L SETD2 NRXN3 NRXN1 AP1B1 AP2B1 ACKR3 IFT122 PCNA SOS1 | 1.35e-03 | 1442 | 99 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | 1.38e-03 | 100 | 99 | 4 | GO:1904029 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.40e-03 | 46 | 99 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 1.43e-03 | 101 | 99 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 1.43e-03 | 101 | 99 | 4 | GO:0033138 | |
| GeneOntologyBiologicalProcess | negative regulation of dendrite development | 1.46e-03 | 12 | 99 | 2 | GO:2000171 | |
| GeneOntologyBiologicalProcess | negative regulation of glycogen biosynthetic process | 1.46e-03 | 12 | 99 | 2 | GO:0045719 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle hypertrophy | 1.49e-03 | 47 | 99 | 3 | GO:0014741 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | APH1B ERBB4 PSEN1 DCUN1D5 GSK3A ADCYAP1 IFNA7 GSK3B IFNA14 USP8 NRXN1 CSNK2A1 SPDYA CAMTA1 CSNK2A3 OAZ3 | 1.52e-03 | 1458 | 99 | 16 | GO:0051247 |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 1.59e-03 | 48 | 99 | 3 | GO:0010737 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.60e-03 | 566 | 99 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KATNAL2 CHD3 GSK3A GSK3B DNAH1 LRPPRC SETD2 YIF1B ASPM WDR35 RABGEF1 IFT122 YWHAQ | 1.63e-03 | 1058 | 99 | 13 | GO:0007017 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | APH1B ERBB4 PSEN1 HTR7 GSK3A ADCYAP1 GSK3B USP8 NRXN3 P2RX4 NRXN1 NRXN2 | 1.66e-03 | 931 | 99 | 12 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | APH1B ERBB4 PSEN1 HTR7 GSK3A ADCYAP1 GSK3B USP8 NRXN3 P2RX4 NRXN1 NRXN2 | 1.66e-03 | 931 | 99 | 12 | GO:0007268 |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.66e-03 | 569 | 99 | 9 | GO:0034329 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 1.35e-04 | 4 | 100 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.73e-04 | 277 | 100 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 4.33e-04 | 31 | 100 | 3 | GO:0030131 | |
| GeneOntologyCellularComponent | gamma-secretase complex | 4.68e-04 | 7 | 100 | 2 | GO:0070765 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ERBB4 PSEN1 CHD4 PLXND1 GSK3B IL1RAPL1 USP8 NRXN3 NRXN1 NRXN2 AP2B1 SPARCL1 | 5.25e-04 | 817 | 100 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | intraciliary transport particle A | 6.23e-04 | 8 | 100 | 2 | GO:0030991 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 7.42e-04 | 85 | 100 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 8.38e-04 | 230 | 100 | 6 | GO:0098562 | |
| Domain | AP_complex_bsu_1_2_4 | 1.40e-07 | 3 | 98 | 3 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.40e-07 | 3 | 98 | 3 | PF09066 | |
| Domain | B-adaptin_app_sub_C | 5.58e-07 | 4 | 98 | 3 | IPR015151 | |
| Domain | B2-adapt-app_C | 5.58e-07 | 4 | 98 | 3 | SM01020 | |
| Domain | AP_beta | 1.39e-06 | 5 | 98 | 3 | IPR026739 | |
| Domain | Beta2_adaptin/TBP_C_dom | 2.77e-06 | 6 | 98 | 3 | IPR012295 | |
| Domain | - | 2.77e-06 | 6 | 98 | 3 | 3.30.310.10 | |
| Domain | Syndecan | 4.83e-06 | 7 | 98 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 4.83e-06 | 7 | 98 | 3 | IPR027789 | |
| Domain | Coatomer/calthrin_app_sub_C | 7.70e-06 | 8 | 98 | 3 | IPR009028 | |
| Domain | - | 2.73e-05 | 2 | 98 | 2 | 2.60.40.1150 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 2.73e-05 | 2 | 98 | 2 | IPR013037 | |
| Domain | Neurexin-like | 4.89e-05 | 14 | 98 | 3 | IPR003585 | |
| Domain | 4.1m | 4.89e-05 | 14 | 98 | 3 | SM00294 | |
| Domain | Clathrin/coatomer_adapt-like_N | 6.09e-05 | 15 | 98 | 3 | IPR002553 | |
| Domain | Adaptin_N | 6.09e-05 | 15 | 98 | 3 | PF01602 | |
| Domain | CHDCT2 | 8.15e-05 | 3 | 98 | 2 | PF08074 | |
| Domain | CHDNT | 8.15e-05 | 3 | 98 | 2 | PF08073 | |
| Domain | DUF1086 | 8.15e-05 | 3 | 98 | 2 | IPR009462 | |
| Domain | DUF1087 | 8.15e-05 | 3 | 98 | 2 | IPR009463 | |
| Domain | CHD_N | 8.15e-05 | 3 | 98 | 2 | IPR012958 | |
| Domain | CHD_C2 | 8.15e-05 | 3 | 98 | 2 | IPR012957 | |
| Domain | DUF1087 | 8.15e-05 | 3 | 98 | 2 | PF06465 | |
| Domain | DUF1086 | 8.15e-05 | 3 | 98 | 2 | PF06461 | |
| Domain | DUF1087 | 8.15e-05 | 3 | 98 | 2 | SM01147 | |
| Domain | DUF1086 | 8.15e-05 | 3 | 98 | 2 | SM01146 | |
| Domain | 14_3_3 | 5.63e-04 | 7 | 98 | 2 | SM00101 | |
| Domain | 1433_1 | 5.63e-04 | 7 | 98 | 2 | PS00796 | |
| Domain | 1433_2 | 5.63e-04 | 7 | 98 | 2 | PS00797 | |
| Domain | 14-3-3_domain | 5.63e-04 | 7 | 98 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 5.63e-04 | 7 | 98 | 2 | IPR023409 | |
| Domain | 14-3-3 | 5.63e-04 | 7 | 98 | 2 | PF00244 | |
| Domain | 14-3-3 | 7.48e-04 | 8 | 98 | 2 | IPR000308 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 9.58e-04 | 9 | 98 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 9.58e-04 | 9 | 98 | 2 | PF02883 | |
| Domain | Alpha_adaptinC2 | 9.58e-04 | 9 | 98 | 2 | SM00809 | |
| Domain | LAM_G_DOMAIN | 1.03e-03 | 38 | 98 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.20e-03 | 40 | 98 | 3 | PF02210 | |
| Domain | LamG | 1.59e-03 | 44 | 98 | 3 | SM00282 | |
| Domain | Coatomer/clathrin_app_Ig-like | 1.74e-03 | 12 | 98 | 2 | IPR013041 | |
| Domain | FERM_M | 1.81e-03 | 46 | 98 | 3 | PF00373 | |
| Domain | - | 2.17e-03 | 49 | 98 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 2.17e-03 | 49 | 98 | 3 | IPR019748 | |
| Domain | FERM_domain | 2.17e-03 | 49 | 98 | 3 | IPR000299 | |
| Domain | Kinase-like_dom | 2.18e-03 | 542 | 98 | 9 | IPR011009 | |
| Domain | Ig_E-set | 2.19e-03 | 104 | 98 | 4 | IPR014756 | |
| Domain | FERM_1 | 2.30e-03 | 50 | 98 | 3 | PS00660 | |
| Domain | FERM_2 | 2.30e-03 | 50 | 98 | 3 | PS00661 | |
| Domain | FERM_3 | 2.30e-03 | 50 | 98 | 3 | PS50057 | |
| Domain | Band_41_domain | 2.30e-03 | 50 | 98 | 3 | IPR019749 | |
| Domain | B41 | 2.30e-03 | 50 | 98 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.30e-03 | 50 | 98 | 3 | IPR014352 | |
| Domain | ATPase_dyneun-rel_AAA | 2.38e-03 | 14 | 98 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.38e-03 | 14 | 98 | 2 | PF07728 | |
| Domain | - | 3.17e-03 | 56 | 98 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 3.34e-03 | 57 | 98 | 3 | IPR023753 | |
| Domain | Laminin_G | 3.51e-03 | 58 | 98 | 3 | IPR001791 | |
| Domain | Interferon_alpha/beta/delta | 3.52e-03 | 17 | 98 | 2 | IPR000471 | |
| Domain | Interferon | 3.52e-03 | 17 | 98 | 2 | PF00143 | |
| Domain | IFabd | 3.52e-03 | 17 | 98 | 2 | SM00076 | |
| Domain | INTERFERON_A_B_D | 3.52e-03 | 17 | 98 | 2 | PS00252 | |
| Domain | Protein_kinase_ATP_BS | 3.82e-03 | 379 | 98 | 7 | IPR017441 | |
| Domain | HMG_box_dom | 4.84e-03 | 65 | 98 | 3 | IPR009071 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.80e-06 | 67 | 78 | 6 | M295 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 8.77e-06 | 51 | 78 | 5 | M7955 | |
| Pathway | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | 2.60e-05 | 11 | 78 | 3 | MM14534 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 3.14e-05 | 33 | 78 | 4 | MM14523 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 3.99e-05 | 35 | 78 | 4 | M249 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 4.47e-05 | 36 | 78 | 4 | M271 | |
| Pathway | KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.48e-05 | 13 | 78 | 3 | M47763 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | CHD3 CHD4 GSK3A IFNA7 GSK3B IFNA14 AP2B1 NUP93 YWHAQ SFN SOS1 | 5.31e-05 | 471 | 78 | 11 | M39009 |
| Pathway | PID_PS1_PATHWAY | 1.19e-04 | 46 | 78 | 4 | M70 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.86e-04 | 151 | 78 | 6 | M39801 | |
| Pathway | PID_NFAT_3PATHWAY | 2.07e-04 | 53 | 78 | 4 | M113 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.52e-04 | 301 | 78 | 8 | MM15983 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 2.74e-04 | 57 | 78 | 4 | M48326 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 2.93e-04 | 58 | 78 | 4 | M544 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | CHD3 CHD4 GSK3A IFNA7 GSK3B IFNA14 AP1B1 AP2B1 CSNK2A1 NUP93 YWHAQ ARIH1 SFN SOS1 | 3.26e-04 | 888 | 78 | 14 | M48034 |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 3.87e-04 | 26 | 78 | 3 | M247 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 4.33e-04 | 27 | 78 | 3 | M45550 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 4.33e-04 | 27 | 78 | 3 | M1718 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 5.10e-04 | 67 | 78 | 4 | MM15327 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.93e-04 | 261 | 78 | 7 | MM15676 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 6.03e-04 | 70 | 78 | 4 | MM14824 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 6.23e-04 | 7 | 78 | 2 | M22043 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST | 6.23e-04 | 7 | 78 | 2 | MM15335 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 6.23e-04 | 7 | 78 | 2 | MM14879 | |
| Pathway | REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3 | 6.23e-04 | 7 | 78 | 2 | MM15612 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 6.23e-04 | 7 | 78 | 2 | MM1563 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 6.60e-04 | 126 | 78 | 5 | M16763 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.75e-04 | 532 | 78 | 10 | M27870 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 7.20e-04 | 32 | 78 | 3 | MM15326 | |
| Pathway | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | 7.20e-04 | 32 | 78 | 3 | M571 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | CHD3 CHD4 GSK3A IFNA7 GSK3B IFNA14 P2RX4 AP1B1 AP2B1 CSNK2A1 NUP93 YWHAQ ARIH1 SFN SOS1 | 7.52e-04 | 1081 | 78 | 15 | M27548 |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 7.89e-04 | 33 | 78 | 3 | M39875 | |
| Pathway | REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3 | 8.28e-04 | 8 | 78 | 2 | M27887 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 8.72e-04 | 134 | 78 | 5 | M3574 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.06e-03 | 9 | 78 | 2 | M27156 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.06e-03 | 9 | 78 | 2 | M47699 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.09e-03 | 82 | 78 | 4 | MM15922 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.17e-03 | 143 | 78 | 5 | MM15055 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 1.25e-03 | 85 | 78 | 4 | MM14746 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 1.31e-03 | 299 | 78 | 7 | M41727 | |
| Pathway | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | 1.32e-03 | 10 | 78 | 2 | MM14744 | |
| Pathway | REACTOME_TGFBR3_PTM_REGULATION | 1.32e-03 | 10 | 78 | 2 | MM17232 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.36e-03 | 87 | 78 | 4 | M27617 | |
| Pathway | WP_IL5_SIGNALING | 1.39e-03 | 40 | 78 | 3 | M39392 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 1.44e-03 | 304 | 78 | 7 | MM14960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.61e-03 | 11 | 78 | 2 | M47865 | |
| Pathway | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | 1.61e-03 | 11 | 78 | 2 | M2661 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.61e-03 | 11 | 78 | 2 | M27882 | |
| Pathway | REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN | 1.61e-03 | 11 | 78 | 2 | M39011 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.61e-03 | 11 | 78 | 2 | MM14760 | |
| Pathway | REACTOME_TGFBR3_PTM_REGULATION | 1.61e-03 | 11 | 78 | 2 | M48251 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 1.61e-03 | 11 | 78 | 2 | MM14533 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CHD4 SIN3A GSK3A GSK3B TGM3 YIF1B AP1B1 AP2B1 CSNK2A1 DDX60L YWHAQ POGLUT2 MAPK13 CSNK2A3 SFN SOS1 | 8.50e-09 | 910 | 101 | 16 | 36736316 |
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 32973045 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 38891114 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 16406382 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 31005376 | ||
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 2.38e-08 | 3 | 101 | 3 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 2.38e-08 | 3 | 101 | 3 | 11944992 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 2.38e-08 | 3 | 101 | 3 | 17035546 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 2.38e-08 | 3 | 101 | 3 | 25423136 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 2.38e-08 | 3 | 101 | 3 | 34133920 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 30858964 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 28013231 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 2.38e-08 | 3 | 101 | 3 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 2.38e-08 | 3 | 101 | 3 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 2.38e-08 | 3 | 101 | 3 | 29045040 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 38571813 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 35173587 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 2.38e-08 | 3 | 101 | 3 | 7722633 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 23798682 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 32706374 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 8786425 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 17347997 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 9.49e-08 | 4 | 101 | 3 | 33888718 | |
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 9.49e-08 | 4 | 101 | 3 | 14983056 | |
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 9.49e-08 | 4 | 101 | 3 | 32134527 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 36709330 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 2.37e-07 | 5 | 101 | 3 | 18923512 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 9223334 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 28472659 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 30683685 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 4.72e-07 | 6 | 101 | 3 | 12827191 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 4.72e-07 | 6 | 101 | 3 | 8576240 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 11500362 | ||
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 27932497 | ||
| Pubmed | 1.32e-06 | 8 | 101 | 3 | 37591863 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.32e-06 | 8 | 101 | 3 | 30871858 | |
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 34919427 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 20889716 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 15192701 | ||
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 9707552 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.14e-06 | 289 | 101 | 8 | 23752268 | |
| Pubmed | IPO7 CHD4 SIN3A LRPPRC MDN1 AP1B1 AP2B1 CSTF3 NUP93 YWHAQ CSNK2A3 | 2.60e-06 | 638 | 101 | 11 | 33239621 | |
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 2.81e-06 | 10 | 101 | 3 | 25154416 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 3.50e-06 | 217 | 101 | 7 | 31685992 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 3.60e-06 | 218 | 101 | 7 | 35831895 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | IPO7 CHD4 GSK3B LRPPRC AP1B1 AP2B1 CSNK2A1 NUP93 YWHAQ PCNA SFN | 3.85e-06 | 665 | 101 | 11 | 30457570 |
| Pubmed | Multiple and cooperative phosphorylation events regulate the CREM activator function. | 3.86e-06 | 11 | 101 | 3 | 8404858 | |
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 18551195 | ||
| Pubmed | 5.13e-06 | 12 | 101 | 3 | 9885572 | ||
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 19014373 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24523925 | ||
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 8.35e-06 | 2 | 101 | 2 | 7560064 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16912034 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25833158 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22065737 | ||
| Pubmed | Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue. | 8.35e-06 | 2 | 101 | 2 | 16757548 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 8.35e-06 | 2 | 101 | 2 | 9430716 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19064989 | ||
| Pubmed | The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease. | 8.35e-06 | 2 | 101 | 2 | 18955053 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 8.35e-06 | 2 | 101 | 2 | 14646071 | |
| Pubmed | Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. | 8.35e-06 | 2 | 101 | 2 | 18500637 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25833708 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30709877 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27841351 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30119888 | ||
| Pubmed | Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3. | 8.35e-06 | 2 | 101 | 2 | 23606540 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25724980 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17548347 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19858210 | ||
| Pubmed | Cyclic AMP and glycogen synthase kinase 3 form a regulatory loop in spermatozoa. | 8.35e-06 | 2 | 101 | 2 | 29574946 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19366350 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21502951 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20357757 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7575689 | ||
| Pubmed | Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate. | 8.35e-06 | 2 | 101 | 2 | 16814287 | |
| Pubmed | Differential regulation of STAT family members by glycogen synthase kinase-3. | 8.35e-06 | 2 | 101 | 2 | 18550525 | |
| Pubmed | Glycogen synthase kinase 3 in chronic rhinosinusitis: two faces of a single enzyme in one disease. | 8.35e-06 | 2 | 101 | 2 | 23352529 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19658047 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27284979 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19106108 | ||
| Pubmed | 14-3-3ζ reduces DNA damage by interacting with and stabilizing proliferating cell nuclear antigen. | 8.35e-06 | 2 | 101 | 2 | 25169136 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30790505 | ||
| Pubmed | Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. | 8.35e-06 | 2 | 101 | 2 | 20553816 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25808536 | ||
| Pubmed | Boosting CNS axon regeneration by harnessing antagonistic effects of GSK3 activity. | 8.35e-06 | 2 | 101 | 2 | 28630333 | |
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 8.35e-06 | 2 | 101 | 2 | 12860116 | |
| Pubmed | Regulation of glycogen synthase kinase 3 in human platelets: a possible role in platelet function? | 8.35e-06 | 2 | 101 | 2 | 14550568 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22384031 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 9809441 | ||
| Pubmed | Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. | 8.35e-06 | 2 | 101 | 2 | 19106302 | |
| Pubmed | Glycogen synthase kinase 3 regulates photic signaling in the suprachiasmatic nucleus. | 8.35e-06 | 2 | 101 | 2 | 28244152 | |
| Pubmed | Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3. | 8.35e-06 | 2 | 101 | 2 | 16176184 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22986169 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16934436 | ||
| Interaction | BCR interactions | EGLN3 SIN3A GSK3A GSK3B TULP3 AP2B1 CSNK2A1 YWHAQ SFN SMG6 SOS1 | 3.99e-08 | 244 | 101 | 11 | int:BCR |
| Interaction | CEP170B interactions | 1.96e-07 | 83 | 101 | 7 | int:CEP170B | |
| Interaction | AFTPH interactions | 4.96e-07 | 59 | 101 | 6 | int:AFTPH | |
| Interaction | SYNRG interactions | 2.08e-06 | 75 | 101 | 6 | int:SYNRG | |
| Interaction | NHSL1 interactions | 5.07e-06 | 50 | 101 | 5 | int:NHSL1 | |
| Interaction | PIP5K1C interactions | 5.07e-06 | 50 | 101 | 5 | int:PIP5K1C | |
| Interaction | PPP6R3 interactions | 6.02e-06 | 258 | 101 | 9 | int:PPP6R3 | |
| Interaction | DENND4A interactions | 6.04e-06 | 90 | 101 | 6 | int:DENND4A | |
| Interaction | MAST4 interactions | 8.16e-06 | 26 | 101 | 4 | int:MAST4 | |
| Interaction | HAT1 interactions | 1.36e-05 | 217 | 101 | 8 | int:HAT1 | |
| Interaction | CDC25C interactions | 1.36e-05 | 156 | 101 | 7 | int:CDC25C | |
| Interaction | APC interactions | 2.58e-05 | 389 | 101 | 10 | int:APC | |
| Interaction | MTF2 interactions | 2.86e-05 | 118 | 101 | 6 | int:MTF2 | |
| Interaction | HUS1 interactions | 2.86e-05 | 118 | 101 | 6 | int:HUS1 | |
| Interaction | SIPA1L3 interactions | 2.86e-05 | 118 | 101 | 6 | int:SIPA1L3 | |
| Interaction | GAB1 interactions | 3.19e-05 | 178 | 101 | 7 | int:GAB1 | |
| Interaction | MACF1 interactions | 3.44e-05 | 247 | 101 | 8 | int:MACF1 | |
| Interaction | CEP192 interactions | 5.16e-05 | 192 | 101 | 7 | int:CEP192 | |
| Interaction | PNKD interactions | 5.37e-05 | 132 | 101 | 6 | int:PNKD | |
| Interaction | SIPA1L2 interactions | 6.34e-05 | 136 | 101 | 6 | int:SIPA1L2 | |
| Interaction | TNS3 interactions | 7.64e-05 | 87 | 101 | 5 | int:TNS3 | |
| Interaction | SNAI2 interactions | 8.25e-05 | 46 | 101 | 4 | int:SNAI2 | |
| Interaction | RASSF8 interactions | 9.46e-05 | 91 | 101 | 5 | int:RASSF8 | |
| Interaction | NHS interactions | 9.76e-05 | 48 | 101 | 4 | int:NHS | |
| Interaction | CEP350 interactions | 1.05e-04 | 149 | 101 | 6 | int:CEP350 | |
| Interaction | ZBTB5 interactions | 1.06e-04 | 49 | 101 | 4 | int:ZBTB5 | |
| Interaction | KIF26B interactions | 1.34e-04 | 52 | 101 | 4 | int:KIF26B | |
| Interaction | SLX4 interactions | EGLN3 IPO7 CHD4 GSK3A GSK3B ARID3B TGM3 MDN1 AP1B1 AP2B1 PCNA | 1.38e-04 | 572 | 101 | 11 | int:SLX4 |
| Interaction | CAMSAP1 interactions | 1.41e-04 | 99 | 101 | 5 | int:CAMSAP1 | |
| Interaction | NUB1 interactions | 1.44e-04 | 53 | 101 | 4 | int:NUB1 | |
| Interaction | LYST interactions | 1.44e-04 | 53 | 101 | 4 | int:LYST | |
| Interaction | CTNNB1 interactions | EGLN3 PSEN1 CHD4 GSK3A GSK3B USP8 LRPPRC CSNK2A1 PTPRQ NR5A2 ASPM NUP93 YWHAQ PCNA SFN | 1.47e-04 | 1009 | 101 | 15 | int:CTNNB1 |
| Interaction | PTPN3 interactions | 1.48e-04 | 100 | 101 | 5 | int:PTPN3 | |
| Interaction | MYO9A interactions | 1.55e-04 | 101 | 101 | 5 | int:MYO9A | |
| Interaction | ANKS1A interactions | 1.66e-04 | 162 | 101 | 6 | int:ANKS1A | |
| Interaction | TTC21B interactions | 1.76e-04 | 22 | 101 | 3 | int:TTC21B | |
| Interaction | NLGN1 interactions | 1.76e-04 | 22 | 101 | 3 | int:NLGN1 | |
| Interaction | PPP1R3D interactions | 1.76e-04 | 22 | 101 | 3 | int:PPP1R3D | |
| Interaction | WDR62 interactions | 1.78e-04 | 104 | 101 | 5 | int:WDR62 | |
| Interaction | AKAP11 interactions | 1.78e-04 | 104 | 101 | 5 | int:AKAP11 | |
| Interaction | SPOP interactions | 1.78e-04 | 491 | 101 | 10 | int:SPOP | |
| Interaction | IGF2R interactions | 1.83e-04 | 314 | 101 | 8 | int:IGF2R | |
| Interaction | CCP110 interactions | 1.90e-04 | 166 | 101 | 6 | int:CCP110 | |
| Interaction | DCP1A interactions | 1.90e-04 | 166 | 101 | 6 | int:DCP1A | |
| Interaction | SUFU interactions | 1.94e-04 | 106 | 101 | 5 | int:SUFU | |
| Interaction | TNKS1BP1 interactions | 2.02e-04 | 168 | 101 | 6 | int:TNKS1BP1 | |
| Interaction | EXO1 interactions | 2.05e-04 | 58 | 101 | 4 | int:EXO1 | |
| Interaction | TAB2 interactions | 2.09e-04 | 169 | 101 | 6 | int:TAB2 | |
| Interaction | PACS2 interactions | 2.29e-04 | 24 | 101 | 3 | int:PACS2 | |
| Interaction | OSBPL3 interactions | 2.31e-04 | 110 | 101 | 5 | int:OSBPL3 | |
| Interaction | KIAA0586 interactions | 2.59e-04 | 25 | 101 | 3 | int:KIAA0586 | |
| Interaction | IFT43 interactions | 2.59e-04 | 25 | 101 | 3 | int:IFT43 | |
| Interaction | AFDN interactions | 2.72e-04 | 333 | 101 | 8 | int:AFDN | |
| Interaction | MTCL2 interactions | 2.73e-04 | 114 | 101 | 5 | int:MTCL2 | |
| Interaction | ZNF687 interactions | 2.84e-04 | 115 | 101 | 5 | int:ZNF687 | |
| Interaction | IFTAP interactions | 3.27e-04 | 27 | 101 | 3 | int:IFTAP | |
| Interaction | FAM193B interactions | 3.27e-04 | 27 | 101 | 3 | int:FAM193B | |
| Interaction | PPP6R2 interactions | 3.33e-04 | 119 | 101 | 5 | int:PPP6R2 | |
| Interaction | FBXW7 interactions | LETM2 PSEN1 IPO7 CHD4 SIN3A GSK3B TGM3 LRPPRC AP2B1 NUP93 YWHAQ ARIH1 OSGIN2 SFN SNX5 SMG6 | 3.44e-04 | 1215 | 101 | 16 | int:FBXW7 |
| Interaction | SLBP interactions | 3.58e-04 | 67 | 101 | 4 | int:SLBP | |
| Interaction | ENTR1 interactions | 3.70e-04 | 188 | 101 | 6 | int:ENTR1 | |
| Interaction | HIF1A interactions | 3.74e-04 | 441 | 101 | 9 | int:HIF1A | |
| Interaction | BIRC6 interactions | 3.77e-04 | 265 | 101 | 7 | int:BIRC6 | |
| Interaction | MAP7D3 interactions | 3.87e-04 | 123 | 101 | 5 | int:MAP7D3 | |
| Interaction | HECTD1 interactions | EGLN3 IPO7 CHD3 CHD4 SIN3A GSK3A GSK3B ARID3B MDN1 ASPM NUP93 YWHAQ PCNA SFN | 3.89e-04 | 984 | 101 | 14 | int:HECTD1 |
| Interaction | FIBP interactions | 4.00e-04 | 69 | 101 | 4 | int:FIBP | |
| Interaction | SGK3 interactions | 4.00e-04 | 69 | 101 | 4 | int:SGK3 | |
| Interaction | LIMD1 interactions | 4.02e-04 | 124 | 101 | 5 | int:LIMD1 | |
| Interaction | FOXO3 interactions | 4.02e-04 | 124 | 101 | 5 | int:FOXO3 | |
| Interaction | FAM13A interactions | 4.06e-04 | 29 | 101 | 3 | int:FAM13A | |
| Interaction | HBS1L interactions | 4.17e-04 | 125 | 101 | 5 | int:HBS1L | |
| Interaction | BRMS1L interactions | 4.17e-04 | 125 | 101 | 5 | int:BRMS1L | |
| Interaction | RNF138 interactions | 4.17e-04 | 125 | 101 | 5 | int:RNF138 | |
| Interaction | SNAP91 interactions | 4.23e-04 | 70 | 101 | 4 | int:SNAP91 | |
| Interaction | GPRASP2 interactions | 4.33e-04 | 126 | 101 | 5 | int:GPRASP2 | |
| Interaction | KIAA1671 interactions | 4.37e-04 | 194 | 101 | 6 | int:KIAA1671 | |
| Interaction | FAM193A interactions | 4.46e-04 | 71 | 101 | 4 | int:FAM193A | |
| Interaction | CCDC8 interactions | EGLN3 CPNE8 IPO7 CHD3 CHD4 LRPPRC MDN1 CSNK2A1 NR5A2 NUP93 YWHAQ | 4.46e-04 | 656 | 101 | 11 | int:CCDC8 |
| Interaction | ZFP36L1 interactions | 4.50e-04 | 30 | 101 | 3 | int:ZFP36L1 | |
| Interaction | STIP1 interactions | EGLN3 IPO7 CHD4 SIN3A NEB LRPPRC MDN1 AP1B1 AP2B1 CSNK2A1 CSTF3 NUP93 YWHAQ CSNK2A3 | 4.86e-04 | 1006 | 101 | 14 | int:STIP1 |
| Interaction | LRCH2 interactions | 4.96e-04 | 73 | 101 | 4 | int:LRCH2 | |
| Interaction | CEP131 interactions | 5.14e-04 | 200 | 101 | 6 | int:CEP131 | |
| Interaction | PPP1R2 interactions | 5.22e-04 | 74 | 101 | 4 | int:PPP1R2 | |
| Interaction | CD274 interactions | 5.39e-04 | 369 | 101 | 8 | int:CD274 | |
| Interaction | PTPN13 interactions | 5.41e-04 | 202 | 101 | 6 | int:PTPN13 | |
| Interaction | GRAMD1B interactions | 5.50e-04 | 75 | 101 | 4 | int:GRAMD1B | |
| Interaction | PDPK1 interactions | 5.56e-04 | 203 | 101 | 6 | int:PDPK1 | |
| Interaction | TBC1D4 interactions | 5.93e-04 | 135 | 101 | 5 | int:TBC1D4 | |
| Interaction | SNCAIP interactions | 5.98e-04 | 33 | 101 | 3 | int:SNCAIP | |
| Interaction | PARP10 interactions | 5.98e-04 | 33 | 101 | 3 | int:PARP10 | |
| Interaction | NAP1L4 interactions | 6.00e-04 | 206 | 101 | 6 | int:NAP1L4 | |
| Interaction | DST interactions | 6.07e-04 | 287 | 101 | 7 | int:DST | |
| Interaction | MTUS1 interactions | 6.08e-04 | 77 | 101 | 4 | int:MTUS1 | |
| Interaction | TRAK1 interactions | 6.08e-04 | 77 | 101 | 4 | int:TRAK1 | |
| Interaction | RAPGEF6 interactions | 6.38e-04 | 78 | 101 | 4 | int:RAPGEF6 | |
| Interaction | SIK3 interactions | 6.69e-04 | 79 | 101 | 4 | int:SIK3 | |
| Interaction | TULP1 interactions | 6.83e-04 | 8 | 101 | 2 | int:TULP1 | |
| Interaction | KCNK15 interactions | 6.83e-04 | 8 | 101 | 2 | int:KCNK15 | |
| Interaction | PPP1CA interactions | EGLN3 CHD3 GSK3A GSK3B USP8 CSNK2A1 ASPM RABGEF1 YWHAQ PCNA SFN | 7.29e-04 | 696 | 101 | 11 | int:PPP1CA |
| Interaction | SKP1 interactions | 7.30e-04 | 484 | 101 | 9 | int:SKP1 | |
| Cytoband | 14q31 | 1.71e-04 | 9 | 101 | 2 | 14q31 | |
| Cytoband | 2p21 | 3.39e-04 | 61 | 101 | 3 | 2p21 | |
| Cytoband | 15q24 | 9.79e-04 | 21 | 101 | 2 | 15q24 | |
| Cytoband | 9p22 | 1.39e-03 | 25 | 101 | 2 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 2.52e-03 | 122 | 101 | 3 | chr15q24 | |
| GeneFamily | Atypical chemokine receptors | 1.83e-04 | 6 | 64 | 2 | 1090 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 2.56e-04 | 7 | 64 | 2 | 1053 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.36e-04 | 50 | 64 | 3 | 1293 | |
| GeneFamily | PHD finger proteins|NuRD complex | 7.96e-04 | 12 | 64 | 2 | 1305 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 3.24e-03 | 24 | 64 | 2 | 615 | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-06 | 171 | 101 | 6 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-06 | 171 | 101 | 6 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-06 | 180 | 101 | 6 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-06 | 180 | 101 | 6 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.37e-06 | 106 | 101 | 5 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.37e-06 | 106 | 101 | 5 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.37e-06 | 106 | 101 | 5 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cpa6_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.81e-05 | 142 | 101 | 5 | 84742a7e35bab09ee1cca80cfe120b613d6aed6a | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 2.68e-05 | 154 | 101 | 5 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-05 | 157 | 101 | 5 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-05 | 157 | 101 | 5 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-05 | 162 | 101 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_PSRC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-05 | 165 | 101 | 5 | 6de69b75174731931e7e80a3488f983a7ba4defe | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-05 | 175 | 101 | 5 | 98dc3b6f69a29d587f503898f09912700950e3d9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.92e-05 | 175 | 101 | 5 | d4ff1f197ad4086286e86817cbff24fa718293fc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-05 | 175 | 101 | 5 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.20e-05 | 177 | 101 | 5 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.48e-05 | 179 | 101 | 5 | fae869fb0a91428481bf8a9c111dcc639e2b4278 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.63e-05 | 180 | 101 | 5 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.09e-05 | 183 | 101 | 5 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 184 | 101 | 5 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 184 | 101 | 5 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 185 | 101 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 185 | 101 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-05 | 185 | 101 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.74e-05 | 187 | 101 | 5 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 6.74e-05 | 187 | 101 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 7.09e-05 | 189 | 101 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 7.09e-05 | 189 | 101 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.45e-05 | 191 | 101 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.64e-05 | 192 | 101 | 5 | 694626965faee8b7c4e5bb78d554f62ba8dbc423 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.82e-05 | 193 | 101 | 5 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.02e-05 | 194 | 101 | 5 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-05 | 194 | 101 | 5 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.21e-05 | 195 | 101 | 5 | eca24039bde02f4677f1f89a373f501c649ec2a5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.62e-05 | 197 | 101 | 5 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-05 | 197 | 101 | 5 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-05 | 198 | 101 | 5 | 63f7d25201613bd3404c28fb936954190bca91d3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-05 | 198 | 101 | 5 | a73534b6ca202c277a70a52281d5b97a3e6cb8ef | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.83e-05 | 198 | 101 | 5 | d1e1bdd36c84e1bac21ba137f018defe98456a8c | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tmem163_Arhgap25|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.46e-04 | 117 | 101 | 4 | e1a14b8413a6f4b194217a90eb2c5f95ab14522e | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-04 | 118 | 101 | 4 | f0f40a0165156e3fc1584480b473b0e84e10d2cc | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.56e-04 | 119 | 101 | 4 | a6b359e7aafcc197f53eb5e19c3a905bc09497bb | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.61e-04 | 120 | 101 | 4 | a6d0406a174d46ce06b41280292931954af88a59 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.66e-04 | 121 | 101 | 4 | b2d571f571133c281d72584fe925cebbd2317829 | |
| Drug | GC-MPT | 6.98e-06 | 9 | 101 | 3 | CID000194264 | |
| Drug | P-38 | ERBB4 GSK3A ADCYAP1 GSK3B IL1RAPL1 SETD2 IL1F10 PRKG2 MMP3 MAPK13 SFN SOS1 | 1.75e-05 | 613 | 101 | 12 | CID000200878 |
| Drug | (-)-Ircinol A | 1.95e-05 | 2 | 101 | 2 | CID005276610 | |
| Drug | AC1L8KDY | 1.95e-05 | 2 | 101 | 2 | CID000382949 | |
| Drug | manzamine A N-oxide | 1.95e-05 | 2 | 101 | 2 | CID006480355 | |
| Drug | Me-6-BIO | 1.95e-05 | 2 | 101 | 2 | CID006538821 | |
| Drug | xestomanzamine A | 1.95e-05 | 2 | 101 | 2 | CID006481130 | |
| Drug | ircinal | 1.95e-05 | 2 | 101 | 2 | CID005270588 | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; HL60; HT_HG-U133A | 2.48e-05 | 193 | 101 | 7 | 1331_DN | |
| Disease | Autism Spectrum Disorders | 8.76e-06 | 85 | 96 | 5 | C1510586 | |
| Disease | Cranioectodermal dysplasia | 6.26e-05 | 4 | 96 | 2 | cv:C4551571 | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 1.04e-04 | 5 | 96 | 2 | C0432235 | |
| Disease | Schizophrenia | ERBB4 HTR7 CHD4 GSK3A ADCYAP1 GSK3B NRXN3 NRXN1 NRXN2 TAAR1 MMP3 | 1.41e-04 | 883 | 96 | 11 | C0036341 |
| Disease | Cerebral ventriculomegaly | 2.18e-04 | 7 | 96 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 2.18e-04 | 7 | 96 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 2.18e-04 | 7 | 96 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 2.18e-04 | 7 | 96 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 2.18e-04 | 7 | 96 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 2.18e-04 | 7 | 96 | 2 | C0549423 | |
| Disease | Congenital Hydrocephalus | 2.90e-04 | 8 | 96 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 2.90e-04 | 8 | 96 | 2 | C2936786 | |
| Disease | Melancholia | 3.25e-04 | 41 | 96 | 3 | C0025193 | |
| Disease | Depression, Neurotic | 3.25e-04 | 41 | 96 | 3 | C0282126 | |
| Disease | Depressive Syndrome | 3.49e-04 | 42 | 96 | 3 | C0086133 | |
| Disease | Depressive disorder | 3.71e-04 | 289 | 96 | 6 | C0011581 | |
| Disease | Hydrocephalus | 3.72e-04 | 9 | 96 | 2 | C0020255 | |
| Disease | Endogenous depression | 4.58e-04 | 46 | 96 | 3 | C0011573 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.52e-04 | 49 | 96 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | pursuit maintenance gain measurement | 7.10e-04 | 123 | 96 | 4 | EFO_0008433 | |
| Disease | Alzheimer disease | 1.05e-03 | 485 | 96 | 7 | MONDO_0004975 | |
| Disease | schizophrenia (biomarker_via_orthology) | 1.07e-03 | 15 | 96 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | Synostotic Posterior Plagiocephaly | 1.22e-03 | 16 | 96 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.22e-03 | 16 | 96 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.22e-03 | 16 | 96 | 2 | C0030044 | |
| Disease | Trigonocephaly | 1.22e-03 | 16 | 96 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.22e-03 | 16 | 96 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.22e-03 | 16 | 96 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.22e-03 | 16 | 96 | 2 | C1860819 | |
| Disease | Multiple congenital anomalies | 1.38e-03 | 17 | 96 | 2 | C0000772 | |
| Disease | Brachycephaly | 1.38e-03 | 17 | 96 | 2 | C0221356 | |
| Disease | Mental Depression | 1.47e-03 | 254 | 96 | 5 | C0011570 | |
| Disease | Autistic Disorder | 1.66e-03 | 261 | 96 | 5 | C0004352 | |
| Disease | Craniosynostosis | 1.92e-03 | 20 | 96 | 2 | C0010278 | |
| Disease | urate measurement | 2.57e-03 | 895 | 96 | 9 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKYLYAYECEKKALS | 296 | Q8IVW6 | |
| YIQEMFRFAYYKLLK | 81 | Q8WW43 | |
| RKLDAVYYYMRSLAA | 781 | Q86US8 | |
| YRALRKYYENCEVVM | 46 | Q15303 | |
| VFYLKMKGDYFRYLA | 116 | P27348 | |
| RCYRKYKQYALYKKM | 1556 | Q9Y6Y1 | |
| YKQYALYKKMTQAAI | 1561 | Q9Y6Y1 | |
| MKYQLLLKDFLKYYN | 296 | Q86VW2 | |
| KKLVYLYLMNYAKSQ | 66 | P63010 | |
| LKMKGDYYRYLAEVA | 121 | P31947 | |
| MNEYNYLKEKLLQYE | 606 | A2A2Z9 | |
| TKLYMAKYADYFLEV | 176 | Q5T5M9 | |
| DIVQKKLVYLYMCTY | 61 | Q9Y6B7 | |
| KKLVYLYLMNYAKSQ | 66 | Q10567 | |
| YQYLEQSKYRVMNKD | 181 | Q9BTE7 | |
| KYYVKERSKAMVACY | 111 | Q9H6Z9 | |
| KARQYYLKMYKAIIV | 1766 | Q8IZT6 | |
| YLKMYKAIIVIQNYY | 1771 | Q8IZT6 | |
| IEMAYARQIYIYNEK | 181 | Q8N1F7 | |
| ILYVFYILIMKYNVK | 236 | Q8NFF2 | |
| RIAKYGKQLYMNYQE | 501 | Q70E73 | |
| IVLYCMKKRLYYREK | 356 | Q99571 | |
| IEKYIMTRLYKYVFC | 211 | Q9UJ41 | |
| KELAYTYVKIINYMI | 171 | Q7Z602 | |
| MVVAIYAYYKKQRTK | 61 | Q9NPB9 | |
| TLMYTYVFAFYLKKN | 471 | Q9Y4X5 | |
| LSMYVQLKKSYSLDY | 256 | Q8NGY5 | |
| MARYYIIKYADQKAL | 6 | Q8WWZ1 | |
| LILLYAMYKYRNRDE | 411 | P58400 | |
| YFQRITLYLMEKKYS | 146 | P01570 | |
| SYRQKIMDELKYYYN | 121 | Q2VYF4 | |
| RLLMNYEDKYYKEVQ | 2761 | Q9NU22 | |
| LYCYKYRITLREKML | 36 | Q9UMX2 | |
| MYQYLDRKLFKEAYQ | 621 | Q9HBG6 | |
| IILVHYLLYKYQMKE | 116 | Q96LZ2 | |
| MNLVQKYLENYYDLK | 31 | P08254 | |
| KAALYEYNLAVMKDF | 1506 | Q5H9U9 | |
| VVEYKIADMGHLKYY | 236 | P12004 | |
| NVAMAEIYKYAKRYR | 1871 | Q9Y4D7 | |
| EIYKYAKRYRPQIMA | 1876 | Q9Y4D7 | |
| KVLYQYKEKQYMAPR | 306 | O95373 | |
| TIYKCYKIEIMLFYR | 376 | Q9NZN1 | |
| ILMEYESYYFVKFQK | 71 | Q8IYT4 | |
| TIEQKMADYSNKLYY | 96 | Q8NCN5 | |
| LKKNMLLYFAYADYE | 336 | Q12996 | |
| DYAVVLRKYADKIYN | 291 | Q9HBA9 | |
| YFQRITLYLMEKKYS | 146 | P01567 | |
| LILLYAMYKYRNRDE | 1651 | Q9P2S2 | |
| CILILLYAMYKYRNR | 1581 | Q9Y4C0 | |
| KIQYLVYQMLKGLKY | 126 | O15264 | |
| QMYYNLLKLYKINGD | 956 | P42704 | |
| LILLYAMYKYRNRDE | 1416 | Q9ULB1 | |
| LLVVKEYEMPLYRKY | 1546 | Q9C091 | |
| LYRTFKDNKYVYMLL | 516 | Q13237 | |
| LEYNSMRLIVSYVYK | 1381 | Q8IVE3 | |
| DQNMYKNVKYIIDKY | 231 | Q5SRI9 | |
| EYKLYEALKFIMLYQ | 236 | Q9NUU6 | |
| YEVLYKNIDTLYMKN | 741 | Q9UMZ3 | |
| MDYYRKYAAIFLVTL | 1 | P01215 | |
| YSRYRKQMAVKKYLA | 141 | P18509 | |
| AYILYKMSDAYHVKR | 486 | Q8N414 | |
| ARYYKHYVKVMGLQK | 176 | Q9Y236 | |
| EHVYMELSQKLYKYC | 66 | Q96NE9 | |
| MIPLQAYAKEYRKYL | 741 | Q9P2D7 | |
| YDIRFYMYEILKALD | 131 | Q8NEV1 | |
| VKVYMYQLFRSLAYI | 221 | P49840 | |
| QYKEMYLFVYRKDAV | 96 | Q92874 | |
| MQKKYYKYILTRNFE | 991 | Q12873 | |
| YFRMYAKEFDLLKYI | 91 | P49326 | |
| KKAYADFYRNYDVMK | 46 | P09669 | |
| IYVKLYMYQLFRSLA | 156 | P49841 | |
| NYRYELMKAFIFKYS | 321 | P25106 | |
| YDIRFYMYEILKALD | 131 | P68400 | |
| AFYMLKGKLQYELQY | 146 | Q9HBE5 | |
| MQKKYYKYILTRNFE | 981 | Q14839 | |
| YNANYIKILRKMLNY | 201 | P54803 | |
| VMEAYYRSLKSVQLY | 396 | Q86YQ8 | |
| IRAISMQAEEYLYYK | 506 | O00482 | |
| ADKYLLAMTFVYFKR | 96 | Q5MJ70 | |
| MTILLVVLYKYRCYK | 146 | P49768 | |
| ILILLYAMYKYRNRD | 576 | Q9HDB5 | |
| LNSYKMVYVIKSEDY | 1171 | Q96ST3 | |
| IKYRGQYQKYALLWM | 476 | Q8WXD0 | |
| RTNIYKNKKDYYDMY | 516 | P40879 | |
| YYDLVKAFMAEIRQY | 201 | Q07889 | |
| SYAQYEKYLKSDNMI | 556 | Q08188 | |
| LFMYYQIYKAARKSA | 256 | P34969 | |
| MAPRDLKAYYAFKIY | 101 | Q96Q77 | |
| RKQYIQYEAFKDMLY | 16 | Q9UBH6 | |
| ITKLKYYFAVDTMYV | 106 | Q5BJH7 | |
| KCSYLMAQLKDYITY | 501 | Q7Z392 | |
| YAAYMFVRKIYAAVK | 626 | Q92544 | |
| KSSEKIVYVYMKLNY | 41 | O60224 | |
| LLLRDFKKNYHMYVY | 576 | Q14515 | |
| MLCVYYRIYLIAKEQ | 206 | Q96RJ0 | |
| RYYMLNIEAAKDLLY | 296 | Q9Y5X3 | |
| YRMYASYKNLKVEIK | 101 | Q6UW63 | |
| YARNKNIHYYFMALK | 1596 | Q9BYW2 | |
| LLYRVNKYVNLVMYF | 166 | Q96CP7 | |
| DYYMLRNGDILEYKK | 71 | Q9Y4G6 | |
| LQAMHREKYPNYKYR | 116 | Q05066 | |
| LYRKANYFFDAAKLM | 936 | Q9P2L0 | |
| VLYMKYVTVYNLIKK | 61 | P40818 | |
| YYMYLEKEENQKIFL | 221 | O75386 | |
| IRIFSKVKYYNVEYM | 1236 | Q5VTT5 | |
| YATQLMNEKKYRADY | 5396 | P20929 |